Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Sherry Aulin > Profile

Sherry Aulin

Affiliations

Chief Financial Officer at Xenon Pharmaceuticals Inc. (XENE), 2024-12-19

Insider Trading: Sales See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
XENE	$41.19	11,510	$474,096.90	0	2024-12-18	Filing
XENE	$41.23	7,199	$296,814.77	0	2024-12-18	Filing
XENE	$39.57	15,355	$607,597.35	0	2022-09-02	Filing